FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Clinical trials for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New tools aim to speed up FSHD drug trials
Knowledge-focused OngoingThis study involves 324 adults with facioscapulohumeral muscular dystrophy (FSHD) across 14 international sites. Researchers are testing two new measurement tools—a functional test called FSHD-COM and a muscle-impedance device—to better track disease progression. The goal is to i…
Matched conditions: FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New tools to track FSHD in wheelchair users
Knowledge-focused OngoingThis study aims to find better ways to measure disease progression in people with advanced facioscapulohumeral muscular dystrophy (FSHD) who use wheelchairs. Researchers will test various muscle strength and function tests over two years in 30 adults. The goal is to develop relia…
Matched conditions: FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC